Latest On Aptorum Group Limited (APM):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-01 19:12 EST | News | Aptorum's subsidiary Paths Innovation to merge with Universal Sequencing Technology, shares up 8.3% | N/A |  |
| 2023-04-29 04:58 EST | News | Aptorum Group GAAP EPS of -$2.75 beats by $2.32, revenue of $1.3M misses by $5.95M | N/A | |
| 2023-03-27 11:34 EST | News | Aptorum Group signs LOI to acquire URF Holding | N/A | |
| 2023-02-11 00:00 EST | News | Aptorum Group regains compliance with nasdaq minimum bid price | N/A | |
| 2023-01-20 15:14 EST | News | Aptorum Group climbs 3%, announces 1-for-10 reverse stock split | N/A | |
About Aptorum Group Limited (APM):
Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers. Its pipeline through the establishment of drug discovery platforms enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. The company is also pursuing therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. It also has projects focused on surgical robotics and natural supplement for women undergoing menopause and experiencing related symptoms. Aptorum Group Limited read more... was incorporated in 2010 and is headquartered in London, the United Kingdom.
General
- Name Aptorum Group Limited
- Symbol APM
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 36
- Last Split Factor3:1
- Last Split Date2011-05-02
- Fiscal Year EndDecember
- IPO Date2018-12-18
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.aptorumgroup.com
Valuation
- Price/Sales (Trailing 12 Mt.) 154.44
- Price/Book (Most Recent Quarter) 5.59
- Enterprise Value Revenue 176.23
Financials
- Most Recent Quarter 2020-06-30
- Current Year EPS Estimate -$0.64
- Next Year EPS Estimate -$0.84
- Operating Margin -2936%
- Return on Assets -48%
- Return on Equity -84%
- Revenue 622647
- Earnings Per Share -$0.65
- Revenue Per Share $0.02
- Gross Profit -259379
- Quarterly Earnings Growth 36.5%
Highlights
- Market Capitalization 108.5 million
- EBITDA -12622395
- Analyst Target Price $13
- Book Value Per Share $0.65
Share Statistics
- Shares Outstanding 11.57 million
- Shares Float 7.43 million
- % Held by Insiders 2643%
- % Held by Institutions 0.77%
- Shares Short 334111
- Shares Short Prior Month 253830
- Short Ratio 0.64
- Short % of Float 4%
- Short % of Shares Outstanding 1%
Technicals
- Beta -0.16
- 52 Week High $4.98
- 52 Week Low $1.16
- 50 Day Moving Average 3.34
- 200 Day Moving Average 2.65
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Aptorum Group Limited (APM) Dividend Calendar:
Aptorum Group Limited (APM) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Aptorum Group Limited (APM) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Aptorum Group Limited (APM) Chart:
Aptorum Group Limited (APM) News:
Below you will find a list of latest news for Aptorum Group Limited (APM) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Aptorum Group Limited (APM) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest APM Trades:
Aptorum Group Limited (APM) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-10-20 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-10-16 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-10-02 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-10-01 | 424B4 (Prospectus [Rule 424(b)(4)]) | |
| 2020-09-29 | CORRESP (Correspondence) | |
| 2020-09-29 | CORRESP (Correspondence) | |
| 2020-09-29 | CORRESP (Correspondence) | |
| 2020-09-29 | F-1MEF (Registration statement to add securities to prior Form F-1 registration [Rule 462(b)]) | |
| 2020-09-29 | EFFECT (Notice of Effectiveness) | |
| 2020-09-28 | UPLOAD (SEC-generated letter) | |
| 2020-09-28 | F-1/A (Registration statement for certain foreign private issuers) | |
| 2020-09-25 | UPLOAD (SEC-generated letter) | |
| 2020-09-25 | F-1/A (Registration statement for certain foreign private issuers) | |
| 2020-09-25 | CORRESP (Correspondence) | |
| 2020-09-24 | F-1/A (Registration statement for certain foreign private issuers) | |
| 2020-09-23 | CORRESP (Correspondence) | |
| 2020-09-22 | UPLOAD (SEC-generated letter) | |
| 2020-09-11 | F-1 (Registration statement for certain foreign private issuers) | |
| 2020-09-02 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |
| 2020-09-01 | 6-K (Report of foreign issuer [Rules 13a-16 and 15d-16]) | |